- Goldman Sachs 42nd Annual Global Healthcare Conference. Fireside chat on
Tuesday, June 8, 2021 at2:10 p.m. ET . JMP Securities Life Sciences Conference . Fireside chat onWednesday, June 16, 2021 at11:00 a.m. ET .J.P. Morgan European Healthcare Conference . Management will participate in investor meetings onThursday, June 17, 2021 .Raymond James Human Health Innovation Conference . Management will participate in a panel discussion onTuesday, June 22, 2021 at12:00 p.m. ET .
Additional information regarding these events will be available on the Company’s website at www.argenx.com.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in
For further information, please contact:
Media:
kkirk@argenx.com
Joke Comijn
jcomijn@argenx.com
Investors:
bdelgiacco@argenx.com
mgreenblatt@argenx.com
Source: argenx SE
2021 GlobeNewswire, Inc., source